Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioids for catheter-related bladder discomfort and emergence agitation after spine surgery
ChiCTR2400081300Phase 4Recruiting
- Sponsor
- Jingzhou Central Hospital
- Start
- Mar 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of butorphanol and nalbuphine in cystitis, Emergence agitation (EA) and postoperative pain (3 arms), sponsored by Jingzhou Central Hospital. Primary endpoints: Catheter-related bladder discomfort score, Numerical rating scale pain score and 4 more. Started Mar 2024; status: recruiting.
02
Drugs
butorphanolnalbuphine
03
Conditions
cystitisEmergence agitation (EA)postoperative pain
Beyond the preview
Go deeper on ChiCTR2400081300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081300.